Donate Life California Honors Senator Ben Allen as Legislator of the Year Donate Life California

PHARMIWEB | PR NEWSWIRE 
SAN DIEGO, April 4, 2017 /PRNewswire/ -- Donate Life California kicked off April as National Donate Life Month by recognizing California Senator Ben Allen as Legislator of the Year for his work on legislation in support of organ, eye and tissue donation. Donate Life California is the state's nonprofit, state-authorized organ, eye and tissue donor registry.

Senator Allen also co-authored a Senate Resolution designating April 2017 as Donate Life/DMV Partnership Month in California, with Senator Tom Berryhill, who received a heart transplant in May 2001. The Donate Life California board of directors witnessed the resolution presentation on the Senate Floor.

"Donate Life California wants to recognize Senator Allen as Donate Life California's Legislator of the Year for his leadership in authoring legislation that decriminalizes organ donation between HIV-positive donors and HIV-positive recipients," said Monica Johnson, Donate Life California Board President. "The implementation of this bill allows us to honor the wishes of people with HIV who choose to be organ donors, and in doing so, saves more lives through donation and transplantation."

Senator Allen authored SB 1408, which amends an outdated California statute to remove a provision that prohibited HIV-positive individuals from donating organs, thus bringing state law in line with federal law under the HOPE (HIV Organ Policy Equity) Act and allowing for organ donation between HIV-positive donors and HIV-positive recipients. Continue reading

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
You have the power to SAVE Lives
Register as an organ, eye and tissue donor
Nationwide:     Organ Donor | Donate Life America
Social Media Declaration: #organdonor #IamADonor

Be sure to share your decision with your family to ensure your generous gift is honored,  At risk is the legacy you wish to leave.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Comments